melanoma
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
Collectively, these results suggest that suppression of PHLPP1 by DNA methylation contributes to melanoma development and progression.
|
24121273 |
2014 |
Degenerative polyarthritis
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Altered Phlpp1 levels are associated with cancer and degenerative diseases such as osteoarthritis.
|
29775231 |
2018 |
Degenerative polyarthritis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Phlpp protein phosphatases are abnormally abundant within human osteoarthritic articular chondrocytes and may contribute to the development of osteoarthritis.
|
29068480 |
2018 |
Malignant neoplasm of gallbladder
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
SNORA74B expression was positively associated with local invasion, advanced TNM stage, CA19-9 level, and Ki67 expression in patients with GBC, while it was negatively associated with expression of PHLPP, an endogenous Akt inhibitor.
|
28212545 |
2017 |
Malignant neoplasm of gallbladder
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer.
|
25895131 |
2015 |
Gallbladder Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
SNORA74B expression was positively associated with local invasion, advanced TNM stage, CA19-9 level, and Ki67 expression in patients with GBC, while it was negatively associated with expression of PHLPP, an endogenous Akt inhibitor.
|
28212545 |
2017 |
Gallbladder Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Increasing PHLPP expression or inhibiting miR-495 expression can induce apoptosis and suppress tumor growth in GBC xenograft model in nude mice.
|
25895131 |
2015 |
Adult Glioblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The highest mean values of PHLPP1 mRNA and protein were found in non-glioma brain tissues whereas the lowest mean values were found in those in glioblastoma with an increase of TNF-α, IL-17, IL-1β (p<0.05).
|
26971226 |
2016 |
Adult Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Restoring the localization of β-TrCP1 to the cytosol of glioblastoma cells rescues the ability of Akt to regulate PHLPP1 stability.
|
21454620 |
2011 |
Childhood Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Restoring the localization of β-TrCP1 to the cytosol of glioblastoma cells rescues the ability of Akt to regulate PHLPP1 stability.
|
21454620 |
2011 |
Childhood Glioblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The highest mean values of PHLPP1 mRNA and protein were found in non-glioma brain tissues whereas the lowest mean values were found in those in glioblastoma with an increase of TNF-α, IL-17, IL-1β (p<0.05).
|
26971226 |
2016 |
Colon Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our previous studies indicated a tumor suppressor role of both PHLPP isoforms in colon cancer.
|
21177869 |
2011 |
Colon Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1.
|
26107137 |
2015 |
Adult Lymphoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling.
|
20574456 |
2010 |
Adult Lymphoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
To determine what the consequences of PHLPP1 loss on BCR signaling are, we downregulated or re-expressed PHLPP1 in lymphoma cell lines and primary CLL B-cells, respectively.
|
20861921 |
2010 |
Childhood Lymphoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
To determine what the consequences of PHLPP1 loss on BCR signaling are, we downregulated or re-expressed PHLPP1 in lymphoma cell lines and primary CLL B-cells, respectively.
|
20861921 |
2010 |
Childhood Lymphoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling.
|
20574456 |
2010 |
Glioblastoma Multiforme
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The highest mean values of PHLPP1 mRNA and protein were found in non-glioma brain tissues whereas the lowest mean values were found in those in glioblastoma with an increase of TNF-α, IL-17, IL-1β (p<0.05).
|
26971226 |
2016 |
Glioblastoma Multiforme
|
0.020 |
Biomarker
|
disease |
BEFREE |
Restoring the localization of β-TrCP1 to the cytosol of glioblastoma cells rescues the ability of Akt to regulate PHLPP1 stability.
|
21454620 |
2011 |
Stage 0 Gallbladder Cancer AJCC v8
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer.
|
25895131 |
2015 |
Stage 0 Gallbladder Cancer AJCC v8
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
SNORA74B expression was positively associated with local invasion, advanced TNM stage, CA19-9 level, and Ki67 expression in patients with GBC, while it was negatively associated with expression of PHLPP, an endogenous Akt inhibitor.
|
28212545 |
2017 |
Stage IIA Gallbladder Cancer AJCC v8
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
SNORA74B expression was positively associated with local invasion, advanced TNM stage, CA19-9 level, and Ki67 expression in patients with GBC, while it was negatively associated with expression of PHLPP, an endogenous Akt inhibitor.
|
28212545 |
2017 |
Stage IIA Gallbladder Cancer AJCC v8
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer.
|
25895131 |
2015 |
Stage IIB Gallbladder Cancer AJCC v8
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
SNORA74B expression was positively associated with local invasion, advanced TNM stage, CA19-9 level, and Ki67 expression in patients with GBC, while it was negatively associated with expression of PHLPP, an endogenous Akt inhibitor.
|
28212545 |
2017 |
Stage IIB Gallbladder Cancer AJCC v8
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer.
|
25895131 |
2015 |